These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 2573326
1. [Efficacy of the combination of low doses of beta-blockers and amiodarone in the treatment of refractory ventricular tachycardia]. Tonet J, Frank R, Fontaine G, Grosgogeat Y. Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1511-7. PubMed ID: 2573326 [Abstract] [Full Text] [Related]
2. Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia. Tonet J, Frank R, Fontaine G, Grosgogeat Y. Pacing Clin Electrophysiol; 1988 Nov; 11(11 Pt 2):1984-9. PubMed ID: 2463576 [Abstract] [Full Text] [Related]
3. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia]. Tonet J, Hidden F, Naditch L, Coutte R, Himbert C, Frank R. Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771 [Abstract] [Full Text] [Related]
4. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery. Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A. G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124 [Abstract] [Full Text] [Related]
5. [Estimation of the long-term efficacy of anti-arrhythmia treatment with flecainide in ventricular tachycardia]. Fauchier JP, Cosnay P, Babuty B, Moquet B, Rouesnel P, Estepo J. Arch Mal Coeur Vaiss; 1990 Jan; 83(1):77-83. PubMed ID: 2106308 [Abstract] [Full Text] [Related]
6. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring]. Tsuchiya M, Kasanuki H, Ohnishi S, Hosoda S. J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400 [Abstract] [Full Text] [Related]
7. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation]. Raviele A, Di Pede F, Delise P, Piccolo E. G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619 [Abstract] [Full Text] [Related]
8. Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone. Tsagalou EP, Kanakakis J, Rokas S, Anastasiou-Nana MI. Int J Cardiol; 2005 Mar 18; 99(2):341-2. PubMed ID: 15749200 [Abstract] [Full Text] [Related]
9. [Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia]. Scanavacca MI, Sosa EA, Lee JH, Bellotti G, Pileggi F. Arq Bras Cardiol; 1990 Jun 18; 54(6):367-71. PubMed ID: 2288524 [Abstract] [Full Text] [Related]
10. "Torsade de pointes" in patients with structural heart disease and atrial fibrillation treated with amiodarone, beta-blockers, and digitalis. Schrickel JW, Schwab JO, Yang A, Bitzen A, Lüderitz B, Lewalter T. Pacing Clin Electrophysiol; 2006 Apr 18; 29(4):363-6. PubMed ID: 16650263 [Abstract] [Full Text] [Related]
11. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Auer J, Weber T, Berent R, Puschmann R, Hartl P, Ng CK, Schwarz C, Lehner E, Strasser U, Lassnig E, Lamm G, Eber B, Study of Prevention of Postoperative Atrial Fibrillation. Am Heart J; 2004 Apr 18; 147(4):636-43. PubMed ID: 15077078 [Abstract] [Full Text] [Related]
12. [Value of beta blockers in the treatment of recurrent ventricular tachycardia in cardiac insufficiency]. Hermida JS, Coumel P, Leclercq JF, Cauchemez B, Maison-Blanche P, Leenhardt A, Slama R. Arch Mal Coeur Vaiss; 1987 Mar 18; 80(3):290-300. PubMed ID: 2887146 [Abstract] [Full Text] [Related]
13. [Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone]. Cassagneau B, Calazel J, Puel J, Massabuau P, Tournadre P, Fauvel JM, Bounhoure JP, Marin T, Narula OS. Arch Mal Coeur Vaiss; 1984 Jul 18; 77(7):766-72. PubMed ID: 6433839 [Abstract] [Full Text] [Related]
14. [Endocavitary transcatheter electric fulguration as a therapeutic alternative in refractory ventricular tachycardia]. Santini M, Ansalone G, Cacciatore G, Di Marcotullio G, Carelli M, Tubaro M, Alexidou G, Bisceglie I. G Ital Cardiol; 1990 Feb 18; 20(2):96-105. PubMed ID: 2328876 [Abstract] [Full Text] [Related]
15. [Amiodarone prophylaxis of ventricular tachycardia in ischemic cardiopathy]. Bernasconi M, Pogna M, Potenza S, Marzegalli M, Cirino D. Cardiologia; 1989 Apr 18; 34(4):357-63. PubMed ID: 2758441 [Abstract] [Full Text] [Related]
16. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A. G Ital Cardiol; 1999 May 18; 29(5):514-23. PubMed ID: 10367218 [Abstract] [Full Text] [Related]
17. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm. Fuchs T, Groysman R, Meilichov I. Pharmacotherapy; 2008 Jan 18; 28(1):14-9. PubMed ID: 18154469 [Abstract] [Full Text] [Related]
18. [Medical treatment of sustained ventricular tachycardia. Retrospective study of 85 patients]. Artigou JY, Isnard R, Faure C, Frank R, Salloum J, Jauffrion P, Grosgogeat Y. Arch Mal Coeur Vaiss; 1989 Jan 18; 82(8):1415-20. PubMed ID: 2508593 [Abstract] [Full Text] [Related]
19. [Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases]. Fleurant E, Lacroix D, Klug D, Warembourg H, Kacet S, Lekieffre J. Arch Mal Coeur Vaiss; 1996 Apr 18; 89(4):435-44. PubMed ID: 8763003 [Abstract] [Full Text] [Related]
20. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated]. Alboni P. Ital Heart J Suppl; 2002 Mar 18; 3(3):337-43. PubMed ID: 12040849 [Abstract] [Full Text] [Related] Page: [Next] [New Search]